PharmaLex Japan, Inc. (formerly Ascent)
Fundamental reforms in Japan have opened the doors to Asia’s pharmaceutical markets as never before. Indeed, Asia is now at the center of global drug development. Our experts work with emerging biopharma to understand and overcome differences in medical practice, culture, and language to achieve optimal integration of Asia into global drug development thus enabling accelerated entry into Asia’s rapidly growing markets.
